A great outcome to our clinical trial. Very excited what POLB 001 can offer patients with inflammatory conditions including severe influenza.
The positive results from our LPS #trial have been published, highlighting the strong potential for #POLB 001 to be a blockbuster for severe #flu
☑️Highly significant reduction of cytokines
💪Potent reduction in systemic & local inflammation
polaris.brighterir.com/publi…
$POLBF
Very encouraging clinical data from our LPS challenge study. A great start to 2023 following a very productive 2022.
Positive initial #data analysis in #POLB 001 LPS challenge trial indicates a successful trial. POLB 001 showed a marked reduction in both systemic & localised inflammatory response & a clear dose-response relationship.
Learn more:
polaris.brighterir.com/publi…
$POLBF #influenza
Highly recommend. Thanks for getting me across the finish line last year, John.
I'll be starting training programmes over the next few weeks for the 2023 Cork City Marathon & Half-Marathon... corkrunning.blogspot.com/202…
Excited that @PoolbegPharma has received this funding to accelerate development of our oral vaccine platform with outstanding collaborators.
Our #POLB led consortium, #EncOVac, has been awarded €2.3m in non-dilutive #grant funding by @DeptEnterprise
The collaboration with @ucddublin, @AnaBio_Tech and @tcddublin will develop an #oralvaccine to a Phase I ready state.
Learn more:
polaris.brighterir.com/publi…
#DTIF $POLBF
Interesting article and angle: Focus has been on preventing severe disease but people who are unlikely to develop severe COVID-19 have no widely approved medications to ease the illness.
'Drugs for mild #COVID19 could mark a turning point in the pandemic. Such a treatment not only would get people back to their lives sooner, but could also limit disease spread... Drugs could help to compensate for low vaccination rates.' @Nature go.nature.com/3aY7IsV
Thank you @TheCorkMarathon for a very well organized run yesterday. Not even the rain could dampen the cheering crowds. Loved running a lap around my hometown and achieving my sub-4 goal. Rest now. 🏃🏻♂️
Terrific 3-1 win for @ShelsAcademy @shelsfc #WNLU17 in the Shield Final v @DLRWaves last night. A great game of football between two talented teams. Delighted Kate opened the scoring with a sweet finish. Thanks to all the coaches! 🔴⚪️⚽️
Super 2-1 win for @ShelsAcademy @shelsfc #WNLU17 in the Shield semi-final yesterday. Battled back well from a goal down playing into a strong breeze. Resilient squad!
Looking forward to presenting at this event in Portsmouth and catching up with @Mike24775926
This quoted post is unavailable.
Another terrific performance and win for the @shelsfc @ShelsAcademy #WNLU17 yesterday. Peaking at the end of the season as the play-offs loom. Bravo girls! 👏
More progress @PoolbegPharma to report. Momentum is building.
Expanding on our existing #PredictViral™ IP, #POLB have filed a new patent application which aims to protect a method of estimating disease severity and contagiousness in people who are recently infected with a respiratory virus.
polaris.brighterir.com/publi…
#infectiousdisease
Another great win for @ShelsAcademy @shelsfc #WNLU17 yesterday. 4 different scorers in a 4-1 win. Gaining momentum at the tail end of the season. Talented, hard working squad.
Another good win for @shelsfc @ShelsAcademy #WNLU17 yesterday. Great effort and teamwork from this talented group of girls. They’ll go far! 🔴⚪️⚽️
Cool - video of Kate’s goal for @shelsfc @ShelsAcademy at the weekend. Nice build up play on the right, super cross and a deft touch after splitting defenders #backofthenet and off to celebrate with the assister. Thanks @WearyOLeary for the clip.
Lovely controlled volley, goal and celebration for Kate as she opened the scoring for @shelsfc @ShelsAcademy v Bohs yesterday in a #WNLU17 3-1 Cup win.
Talented girls working hard in a very entertaining match. 🔴⚪️👏⚽️
Off and running tackling serious viral diseases!
Our #IPO will enable us to fund clinical trial costs associated with the development of our lead asset – POLB-001 – as a treatment for severe #influenza and help us to acquire and develop other portfolio assets.
Discover more on our website: poolbegpharma.com/
#POLB
An exciting day for the @PoolbegPharma team. Important work ahead of us!
Poolbeg Pharma is now a public company following our admission to #AIM on the @LSEplc, ticker #POLB. The IPO provides us with a great platform to begin our rapid growth plan.
You can learn more about what we do on our website: poolbegpharma.com/
#infectiousdisease
















